U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived - Gadodiamide - Document - PDFSEARCH.IO

First Page	Meta Content
	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Open Document File Size: 1,78 MB Share Result on Facebook City Gd / Gadolinium / / Company AES / Bayer / Bayer Schering Pharma / / Event FDA Phase / Product Issues / / IndustryTerm chemical principles / endogenous trace metal levels / contrast-enhanced magnetic resonance imaging / / MedicalCondition Nephrogenic Systemic Fibrosis / CMD / dissociation / / MedicalTreatment intravenous infusion / / Organization National Science Foundation / U.S. Food and Drug Administration / i.v. administration / / Person MRI NDA NFD NMR NOAEL / / Position General / / Product Magnevist / DTPA / Omniscan / Calcium Chloride / EOVIST INJECTION / rats / Copper Deoxyribonucleic Acid / Monocyte Chemoattractant Proteins / EOVIST / / Technology Spectroscopy / X-ray / magnetic resonance imaging / tomography / MRI / / SocialTag Gadodiamide Nephrogenic systemic fibrosis Gadopentetic acid Magnetic resonance imaging Gadoxetic acid Pentetic acid Contrast medium MRI contrast agent Chemistry Matter

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archivedAdd to Reading List